Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.

Abu El-Asrar AM, Ahmad A, Siddiquei MM, De Zutter A, Allegaert E, Gikandi PW, De Hertogh G, Van Damme J, Opdenakker G, Struyf S.

Front Immunol. 2019 Dec 4;10:2752. doi: 10.3389/fimmu.2019.02752. eCollection 2019.

2.

Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis.

Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S.

Eye (Lond). 2019 Dec 5. doi: 10.1038/s41433-019-0693-7. [Epub ahead of print]

PMID:
31804623
3.

Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.

AlBloushi AF, Alfawaz AM, AlZaid A, Alsalamah AK, Gikandi PW, Abu El-Asrar AM.

Ocul Immunol Inflamm. 2019 Oct 22:1-9. doi: 10.1080/09273948.2019.1668430. [Epub ahead of print]

PMID:
31638886
4.

Interleukin-11 Overexpression and M2 Macrophage Density are Associated with Angiogenic Activity in Proliferative Diabetic Retinopathy.

Abu El-Asrar AM, Ahmad A, Allegaert E, Siddiquei MM, Gikandi PW, De Hertogh G, Opdenakker G.

Ocul Immunol Inflamm. 2019 Aug 12:1-14. doi: 10.1080/09273948.2019.1616772. [Epub ahead of print]

PMID:
31403827
5.

Galectin-1 studies in proliferative diabetic retinopathy.

Abu El-Asrar AM, Ahmad A, Allegaert E, Siddiquei MM, Alam K, Gikandi PW, De Hertogh G, Opdenakker G.

Acta Ophthalmol. 2020 Feb;98(1):e1-e12. doi: 10.1111/aos.14191. Epub 2019 Jul 18.

PMID:
31318490
6.

Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities.

Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S.

Ocul Immunol Inflamm. 2019 Jun 4:1-10. doi: 10.1080/09273948.2019.1604974. [Epub ahead of print]

PMID:
31161935
7.

Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.

Abu El-Asrar AM, AlBloushi AF, Gikandi PW, Hardarson SH, Stefánsson E.

Br J Ophthalmol. 2019 Dec;103(12):1695-1699. doi: 10.1136/bjophthalmol-2018-313719. Epub 2019 Feb 23.

PMID:
30798260
8.

Expression of interleukin (IL)-10 family cytokines in aqueous humour of patients with specific endogenous uveitic entities: elevated levels of IL-19 in human leucocyte antigen-B27-associated uveitis.

Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S.

Acta Ophthalmol. 2019 Aug;97(5):e780-e784. doi: 10.1111/aos.14039. Epub 2019 Feb 13.

PMID:
30761764
9.

Pediatric open-globe injury in a university-based tertiary hospital.

AlDahash F, Mousa A, Gikandi PW, Abu El-Asrar AM.

Eur J Ophthalmol. 2020 Mar;30(2):269-274. doi: 10.1177/1120672118818013. Epub 2018 Dec 12.

PMID:
30539664
10.

The CC chemokines CCL8, CCL13 and CCL20 are local inflammatory biomarkers of HLA-B27-associated uveitis.

Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S.

Acta Ophthalmol. 2019 Feb;97(1):e122-e128. doi: 10.1111/aos.13835. Epub 2018 Sep 21.

11.

Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease.

Othman TM, Mousa A, Gikandi PW, AbdelMabod M, Abdelrahman AM.

Saudi J Ophthalmol. 2018 Jul-Sep;32(3):217-221. doi: 10.1016/j.sjopt.2018.06.001. Epub 2018 Jun 14.

12.

Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Uveitis in a University Referral Hospital in Riyadh, Saudi Arabia.

AlBloushi AF, Alfawaz AM, Al-Dahmash SA, Al Owaifeer AM, AlEnezi SH, Al-Fakhri AS, Gikandi PW, Abu El-Asrar AM.

Ocul Immunol Inflamm. 2019;27(7):1105-1113. doi: 10.1080/09273948.2018.1504970. Epub 2018 Aug 24.

PMID:
30142008
13.

Comparison of Goldmann Applanation, Noncontact Air Puff, and Tono-Pen XL Tonometry in Normal Controls versus Glaucoma Patients at a University Hospital in Riyadh, Saudi Arabia.

Osman EA, Gikandi PW, Al-Jasser AA, Alotaibi M, Mousa A.

Middle East Afr J Ophthalmol. 2018 Jan-Mar;25(1):8-13. doi: 10.4103/meajo.MEAJO_291_16.

14.

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.

Abu El-Asrar AM, Mohammad G, Allegaert E, Ahmad A, Siddiquei MM, Alam K, Gikandi PW, De Hertogh G, Opdenakker G.

Mol Vis. 2018 May 18;24:394-406. eCollection 2018.

15.

Differential CXC and CX3C Chemokine Expression Profiles in Aqueous Humor of Patients With Specific Endogenous Uveitic Entities.

El-Asrar AMA, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S.

Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2222-2228. doi: 10.1167/iovs.17-23225.

PMID:
29715366
16.
17.

Compliance of Glaucoma Patients to Ocular Hypotensive Medications Among the Saudi Population.

Osman EA, Alqarni BA, AlHasani SS, Al Harbi SS, Gikandi PW, Mousa A.

J Ocul Pharmacol Ther. 2016 Jan-Feb;32(1):50-4. doi: 10.1089/jop.2015.0052. Epub 2015 Nov 24.

PMID:
26600401
18.

Vitreous hemorrhage in pediatric age group.

AlHarkan DH, Kahtani ES, Gikandi PW, Abu El-Asrar AM.

J Ophthalmol. 2014;2014:497083. doi: 10.1155/2014/497083. Epub 2014 Nov 19.

19.

Patterns of Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia.

Al Dhahri H, Al Rubaie K, Hemachandran S, Mousa A, Gikandi PW, Al-Mezaine HS, Abu El-Asrar AM.

Ocul Immunol Inflamm. 2015 Aug;23(4):311-319. doi: 10.3109/09273948.2014.939197. Epub 2014 Jul 24.

PMID:
25058456
20.

Developing geostatistical space-time models to predict outpatient treatment burdens from incomplete national data.

Gething PW, Noor AM, Gikandi PW, Hay SI, Nixon MS, Snow RW, Atkinson PM.

Geogr Anal. 2008 Apr;40(2):167-188.

21.

Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya.

Gikandi PW, Noor AM, Gitonga CW, Ajanga AA, Snow RW.

Trop Med Int Health. 2008 Feb;13(2):208-17. doi: 10.1111/j.1365-3156.2007.01992.x.

22.

The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide.

Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, Snow RW.

PLoS Med. 2008 Feb;5(2):e38. doi: 10.1371/journal.pmed.0050038.

23.

Information for decision making from imperfect national data: tracking major changes in health care use in Kenya using geostatistics.

Gething PW, Noor AM, Goodman CA, Gikandi PW, Hay SI, Sharif SK, Atkinson PM, Snow RW.

BMC Med. 2007 Dec 11;5:37.

24.

The decline in paediatric malaria admissions on the coast of Kenya.

Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh K, Snow RW.

Malar J. 2007 Nov 15;6:151.

25.

A local space-time kriging approach applied to a national outpatient malaria dataset.

Gething P, Atkinson P, Noor A, Gikandi P, Hay S, Nixon M.

Comput Geosci. 2007 Oct;33(10):1337-1350.

26.

Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project.

Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, Noor AM, Snow RW.

Malar J. 2007 Feb 16;6:17. Review.

27.

Improving imperfect data from health management information systems in Africa using space-time geostatistics.

Gething PW, Noor AM, Gikandi PW, Ogara EA, Hay SI, Nixon MS, Snow RW, Atkinson PM.

PLoS Med. 2006 Jun;3(6):e271.

28.

Supplemental Content

Loading ...
Support Center